NCT06518590

Brief Summary

This study will be conducted to investigate the effect of single limb cycling exercise and the effect of double limb cycling exercise on blood flow in patients with peripheral artery disease and compare between both effects.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
75

participants targeted

Target at P75+ for phase_1

Timeline
Completed

Started Jul 2024

Shorter than P25 for phase_1

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2024

Completed
18 days until next milestone

First Submitted

Initial submission to the registry

July 19, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 24, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

July 24, 2024

Status Verified

July 1, 2024

Enrollment Period

4 months

First QC Date

July 19, 2024

Last Update Submit

July 19, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Blood flow velocity by Doppler

    Blood flow (velocity) and circulation: which will be measured by the doppler ultrasonogrophy at the begining and at the end of the study. \- Doppler ultrasonogrophy of the lower extremity arteries, from common femoral to pedal arteries peak systolic velocity (PSV) recorded in meters per second (Ugwu.,et al .,2021 ) .The normal peak systolic velocity (PSV ) in peripheral lower limb arteries varies from 45-180 cm/s . Severe arterial disease manifests as a PSV in excess of 200 cm/s , monophasic waveform and spectral broading of the doppler wave form .

    baseline

Secondary Outcomes (3)

  • Functional capacity test (6 Min walk test )

    baseline

  • The ankle -brachial index test

    baseline

  • Walking impairment questionnaire

    baseline

Study Arms (3)

Group(A)

ACTIVE COMPARATOR

Twenty five patients will receive unilateral limb training sequentially (counter weighted single limb cycling ) (dominant limb, then non-dominant limb) by bicycle for 20-30 minutes per session, three sessions per week for 2 months (8 weeks), in addition to health advices and their medications

Device: Cycle

Group(B)

ACTIVE COMPARATOR

Twenty-five patients will receive bilateral limbs training by bicycle for 20\_ 30 minutes per session, three sessions per week for 2 months (8 weeks), in addition to health advices and their medications

Device: Cycle

Group(C)

ACTIVE COMPARATOR

Twenty five patients will receive medications in addition to health advices.

Device: Cycle

Interventions

CycleDEVICE

Kettler upright bike Giro P:

Group(A)Group(B)Group(C)

Eligibility Criteria

Age40 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \. Mild to moderate PAD ( ABI ranges from less than 0.90 to 0.50) 2. Intermittent claudication / Typical claudication 3. Their age will be ranged from 50\_60 years old. 4. Quitting smoking for more than 3 months 5. Body mass index (BMI) from 25.0 to 29.9kg/m2.

You may not qualify if:

  • \. Patients with uncontrolled pulmonary disease. 2. Patients with vascular severe complication as critical limb ischemia(ABI less than 0.5) 3. Patients with unstable angina, uncontrolled cardiac arrhythmia, decompensated heart failure.
  • \. Patients with severe musculoskeletal problems (e.g., severe knee osteoarthritis or post knee replacement surgeries).
  • \. Any patients who missed more than two weeks of the program or want to terminate the program.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • Firnhaber JM, Powell CS. Lower Extremity Peripheral Artery Disease: Diagnosis and Treatment. Am Fam Physician. 2019 Mar 15;99(6):362-369.

    PMID: 30874413BACKGROUND
  • Bevan GH, White Solaru KT. Evidence-Based Medical Management of Peripheral Artery Disease. Arterioscler Thromb Vasc Biol. 2020 Mar;40(3):541-553. doi: 10.1161/ATVBAHA.119.312142. Epub 2020 Jan 30.

    PMID: 31996023BACKGROUND

MeSH Terms

Conditions

Peripheral Arterial Disease

Interventions

Plyometric Exercise

Condition Hierarchy (Ancestors)

AtherosclerosisArteriosclerosisArterial Occlusive DiseasesVascular DiseasesCardiovascular DiseasesPeripheral Vascular Diseases

Intervention Hierarchy (Ancestors)

Exercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesPhysical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Central Study Contacts

Merna Marwan Mohamed, B.Sc.

CONTACT

Ahmad MAHDI AHMED, Assistant Professor

CONTACT

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
physical therapist

Study Record Dates

First Submitted

July 19, 2024

First Posted

July 24, 2024

Study Start

July 1, 2024

Primary Completion

November 1, 2024

Study Completion

December 1, 2024

Last Updated

July 24, 2024

Record last verified: 2024-07